Does XALKORI Cause Interstitial lung disease? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Interstitial lung disease have been filed in association with XALKORI. This represents 2.2% of all adverse event reports for XALKORI.
12
Reports of Interstitial lung disease with XALKORI
2.2%
of all XALKORI reports
2
Deaths
8
Hospitalizations
How Dangerous Is Interstitial lung disease From XALKORI?
Of the 12 reports, 2 (16.7%) resulted in death, 8 (66.7%) required hospitalization, and 3 (25.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XALKORI. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does XALKORI Cause?
Disease progression (125)
Death (90)
Lung neoplasm malignant (67)
Nausea (64)
Diarrhoea (43)
Fatigue (32)
Vomiting (29)
Constipation (27)
Oedema peripheral (27)
Off label use (26)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)